Summary

Market Size & Trends

The India continuous glucose monitoring devices market size was estimated at USD 138.9 million in 2024 and is projected to reach USD 672.9 million by 2033, growing at a CAGR of 19.1% from 2025 to 2033. A shift toward proactive diabetes management and the adoption of digital health tools are fueling demand. The rising geriatric population and sedentary lifestyles contribute to the disease burden, necessitating the development of advanced monitoring solutions. Furthermore, expanding healthcare infrastructure, the availability of CGM devices through e-commerce and pharmacies, and collaborations between global players and Indian healthcare providers enhance accessibility. Technological advancements such as sensor accuracy, app integration, and data sharing further support market growth across urban and semi-urban areas.

India, a key country in the International Diabetes Federation (IDF) South-East Asia region, is grappling with a growing diabetes crisis. Of the 589 million global diabetes cases, 107 million are in this region. By 2050, the regional number is expected to rise to 185 million. India alone has a staggering 89.8 million adult diabetes cases, with a 10.5% adult prevalence rate among its 947 million adult population.

To raise awareness and promote better care, World Diabetes Day is observed every year on November 14. The 2024 theme, “Breaking Barriers, Bridging Gaps,” emphasizes collaborative action to improve diagnosis, treatment, and equal access to care. It also encourages health systems to address care disparities and foster inclusion.

India Continuous Glucose Monitoring Devices Market Report Segmentation

This report forecasts revenue growth at country levels and analyzes the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the India CGM devices market report based on product, connectivity, indication and distribution channel:

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Standalone CGM Devices
o Devices
o Consumables (Receivers, Sensors, and Transmitters)
• Integrated CGM-Insulin Pump Systems
• Connectivity Outlook (Revenue, USD Million, 2021 - 2033)
• Bluetooth
• 4G/Cellular
• NFC (Near Field Communication)
• Indication Outlook (Revenue, USD Million, 2021 - 2033)
• Type 1 Diabetes
• Type 2 Diabetes
• Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
• Pharmacies
• E-commerce
• Others

ページTOPに戻る

Table of Contents

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. India CGM Devices Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. India CGM Devices Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
Chapter 4. India CGM Devices Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. India Continuous Glucose Monitoring Devices Market Product Movement Analysis
4.3. India Continuous Glucose Monitoring Devices Market Size & Trend Analysis, by Product, 2024 to 2033 (USD Million)
4.4. Standalone CGM Devices
4.4.1. Standalone CGM Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4.1.1. Devices
4.4.1.1.1. Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4.1.2. Consumables (Receivers, Sensors, and Transmitters)
4.4.1.2.1. Consumables (Receivers, Sensors, and Transmitters) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5. Integrated CGM-Insulin Pump Systems
4.5.1. Integrated CGM-Insulin Pump Systems Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 5. India CGM Devices Market: Connectivity Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. India Continuous Glucose Monitoring Devices Market Connectivity Movement Analysis
5.3. India Continuous Glucose Monitoring Devices Market Size & Trend Analysis, by Connectivity, 2024 to 2033 (USD Million)
5.4. Bluetooth
5.4.1. Bluetooth market revenue estimates and forecasts, 2021 - 2033 (USD Million)
5.5. 4G/Cellular
5.5.1. 4G/Cellular market revenue estimates and forecasts, 2021 - 2033 (USD Million)
5.6. NFC (Near Field Communication)
5.6.1. NFC (Near Field Communication) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Chapter 6. India CGM Devices Market: Indication Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. India Continuous Glucose Monitoring Devices Market Indication Movement Analysis
6.3. India Continuous Glucose Monitoring Devices Market Size & Trend Analysis, by Indication, 2024 to 2033 (USD Million)
6.4. Type 1 Diabetes
6.4.1. Type 1 Diabetes Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5. Type 2 Diabetes
6.5.1. Type 2 Diabetes Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 7. India CGM Devices Market: Distribution Channel Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. India Continuous Glucose Monitoring Devices Market Distribution Channel Movement Analysis
7.3. India Continuous Glucose Monitoring Devices Market Size & Trend Analysis, by Distribution Channel, 2025 to 2033 (USD Million)
7.4. Pharmacies
7.4.1. Pharmacies Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5. E-commerce
7.5.1. E-commerce Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
7.6. Others
7.6.1. Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis by Key Market Participants
8.2. Company Categorization
8.3. Company Heat Map Analysis
8.4. Company Profiles
8.4.1. Abbott Laboratories
8.4.1.1. Company overview
8.4.1.2. Financial performance
8.4.1.3. Product benchmarking
8.4.1.4. Strategic initiatives
8.4.2. Dexcom Inc.
8.4.2.1. Company overview
8.4.2.2. Financial performance
8.4.2.3. Product benchmarking
8.4.2.4. Strategic initiatives
8.4.3. Medtronic PLC
8.4.3.1. Company overview
8.4.3.2. Financial performance
8.4.3.3. Product benchmarking
8.4.3.4. Strategic initiatives
8.4.4. Ascensia Diabetes Care
8.4.4.1. Company overview
8.4.4.2. Financial performance
8.4.4.3. Product benchmarking
8.4.4.4. Strategic initiatives
8.4.5. Roche Diagnostics India
8.4.5.1. Company overview
8.4.5.2. Financial performance
8.4.5.3. Product benchmarking
8.4.5.4. Strategic initiatives
8.4.6. Nemaura Medical
8.4.6.1. Company overview
8.4.6.2. Financial performance
8.4.6.3. Product benchmarking
8.4.6.4. Strategic initiatives
8.4.7. DrStore Healthcare Services India Pvt Ltd
8.4.7.1. Company overview
8.4.7.2. Financial performance
8.4.7.3. Product benchmarking
8.4.7.4. Strategic initiatives
8.4.8. Ultrahuman
8.4.8.1. Company overview
8.4.8.2. Financial performance
8.4.8.3. Product benchmarking
8.4.8.4. Strategic initiatives
8.4.9. Actofit
8.4.9.1. Company overview
8.4.9.2. Financial performance
8.4.9.3. Product benchmarking
8.4.9.4. Strategic initiatives
8.4.10. AmiciCare
8.4.10.1. Company overview
8.4.10.2. Financial performance
8.4.10.3. Product benchmarking
8.4.10.4. Strategic initiatives